IRCCS-Istituto Europeodi Oncologia The European Institute of Oncology IEO

Milan 20141

0 studies enrolling now · 2 studies all time

What they study most

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Squamous Cell Carcinoma of the Head and Neck

Studies at this site

• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed